AXIS Focused Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

AXIS Focused Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

stock1

AXIS Focused Fund - Direct (G)

8.66%

stock2

Nippon India Pharma Fund - Direct (G)

19.87%

Graph not available
Graph not available

About Fund

-

-

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Very High Risk

100

12346.51

1.79

61.34

January 1, 2013

0

Very High Risk

5000

8080.97

1.12

559.3321

January 1, 2013

1

17.61 %

8.91 %

8.66 %

23.7 %

20.86 %

19.87 %

Hitesh Das

PGDM, M.Tech, B.Tech

 Equity Research Analyst - Barclays Securities India Pvt. Ltd. (January 2012 - June 2015)  Equity Research Analyst - Credit Suisse Securities (India) Pvt. Ltd. (July 2011 - December 2012)  Equity Research Analyst - Ebusinessware (India) Pvt. Ltd. (February 2011 - June 2011)  Risk Analyst - Yes Bank (May 2010 - February 2011)

Jinesh Gopani

M.M.S in Finance from Mumbai University

He has total experience of 13 years in the capital markets of which 4 years are in equity fund management. Previous experience includes Birla Sun Life Mutual Fund and Voyager Capital.

Pankaj Murarka

B.Com,ACA

He has Over 16 Years of experience in equity markets. Axis AMC as Fund Manager - Equity from November 2009 to till date. Before Joining to Axis he has worked in Amc like UTI Amc ,DSP Merrill Lynch Capital ,Motilal Oswal and Rare Enterprises.

Sachin Relekar

MMS (Finance), B.E. Mechanical

Prior to joining LIC Mutual Fund he has worked with Tata AMC,Sundaram AMC, CD Equity Search, Innovision Consulting and Tech Pacific India.

Sudhanshu Asthana

Post graduate in Economics and has diploma in Investment Management

He has overall 13 years experience as an equity fund manager. Previous experience includes Barclays Wealth India and SBI Fund Management.

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Get your FAQs right

When comparing AXIS Focused Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G), consider factors such as historical performance, expense ratios, investment strategy, risk level, and the fund manager's credibility. Moreover, look at asset allocation and how each fund fits your investment goals.
Yes, you can invest in both AXIS Focused Fund - Direct (G) and Nippon India Pharma Fund - Direct (G) at the same time. This can help diversify your portfolio and balance risk, provided the fund manager's investment strategies streamline each other.
While comparing AXIS Focused Fund - Direct (G) and Nippon India Pharma Fund - Direct (G), the portfolio turnover ratio indicates how frequently assets within the fund are bought and sold. A high turnover may lead to higher transaction costs and tax implications, while a low turnover ratio indicates a buy-and-hold strategy.
Yes, you can typically switch between AXIS Focused Fund - Direct (G) and Nippon India Pharma Fund - Direct (G), subject to the fund's policies and any applicable fees. It is important to consider potential tax implications and the timing of your switch.
Yes, you can compare AXIS Focused Fund - Direct (G) and Nippon India Pharma Fund - Direct (G) based on their dividend payouts. Look at dividends profit, consistency, and growth, as these factors can influence your overall return on investment.

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions